SCHEMBL22668992

SCHEMBL22668992

FC(F)(F)c1ccncc1N1CCCCC1

nearest known ligand 0.47

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 5/20 0.47
AR P10275 1/20 0.43
KDR P35968 1/20 0.42
SRPK2 P78362 1/20 0.42
SRPK1 Q96SB4 1/20 0.42
SRPK3 Q9UPE1 1/20 0.42
CHKA P35790 1/20 0.41
LATS1 O95835 1/20 0.41
TRPV1 Q8NER1 4/20 0.40
SCD5 Q86SK9 1/20 0.40
MAPT P10636 1/20 0.39
HTT P42858 1/20 0.39
GAA P10253 1/20 0.39
KMT2A Q03164 1/20 0.38
CNR2 P34972 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22669012 0.98 NOTUM (0.48) NOTUMARKDRSRPK2SRPK1
SCHEMBL30582931 0.89 NOTUM (0.42) NOTUMARKDRSRPK2SRPK1
SCHEMBL30582874 0.89 NOTUM (0.42) NOTUMARKDRSRPK2SRPK1
SCHEMBL30582898 0.87 NOTUM (0.40) NOTUMARKDRSRPK2SRPK1
SCHEMBL30582873 0.87 NOTUM (0.40) NOTUMARKDRSRPK2SRPK1
SCHEMBL24008739 0.86 NOTUM (0.47) NOTUMARKDRSRPK2SRPK1
SCHEMBL22657890 0.79 PIM2 (0.39) NOTUMGAAKMT2A
SCHEMBL28705798 0.79 PIM2 (0.39) NOTUMGAAKMT2A
SCHEMBL27307160 0.77 CYP46A1 (0.40) ARTRPV1GAAKMT2ACNR2
SCHEMBL30582883 0.76 NOTUM (0.42) NOTUMKDRSRPK2SRPK1SRPK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021224864-A1 NON-LYSOSOMAL GLUCOSYLCERAMIDASE INHIBITORS AND USES THEREOF ALECTOS THERAPEUTICS INC. (CA) 2021-11-11 WO disclosed
WO-2020229968-A1 NON-LYSOSOMAL GLUCOSYLCERAMIDASE INHIBITORS AND USES THEREOF ALECTOS THERAPEUTICS INC. (CA) 2020-11-19 WO disclosed